1. Home
  2. KALV vs NAT Comparison

KALV vs NAT Comparison

Compare KALV & NAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.79

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Nordic American Tankers Limited

NAT

Nordic American Tankers Limited

HOLD

Current Price

$5.52

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
NAT
Founded
N/A
1995
Country
United States
Bermuda
Employees
N/A
18
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2014
1997

Fundamental Metrics

Financial Performance
Metric
KALV
NAT
Price
$26.79
$5.52
Analyst Decision
Strong Buy
Sell
Analyst Count
5
2
Target Price
$32.60
$4.00
AVG Volume (30 Days)
5.4M
3.4M
Earning Date
07-09-2026
05-28-2026
Dividend Yield
N/A
8.50%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,000,000.00
N/A
Revenue This Year
$185.42
$77.72
Revenue Next Year
$59.23
N/A
P/E Ratio
N/A
$525.49
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$2.55
52 Week High
$26.85
$6.34

Technical Indicators

Market Signals
Indicator
KALV
NAT
Relative Strength Index (RSI) 74.93 44.40
Support Level $14.25 $5.39
Resistance Level $26.85 $6.30
Average True Range (ATR) 0.07 0.19
MACD -0.19 -0.03
Stochastic Oscillator 75.00 18.25

Price Performance

Historical Comparison
KALV
NAT

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About NAT Nordic American Tankers Limited

Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.

Share on Social Networks: